Who are Coenzyme Q10 (drug)'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Q10 Coenzyme.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/coenzyme-q10-drug.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Coenzyme Q10 (drug) — Competitive Intelligence Brief

Coenzyme Q10 (drug) (Coenzyme Q10 (drug)) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Mitochondrial cofactor / Antioxidant. Area: Cardiovascular, Neurology, Metabolic disorders.

marketed Mitochondrial cofactor / Antioxidant Mitochondrial electron transport chain (Complexes I-III, Complex IV) Cardiovascular, Neurology, Metabolic disorders Small molecule Live · refreshed every 30 min

Target snapshot

Coenzyme Q10 (drug) (Coenzyme Q10 (drug)) — University of Shizuoka. Coenzyme Q10 acts as an electron carrier in the mitochondrial electron transport chain, facilitating ATP production and providing antioxidant protection.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Coenzyme Q10 (drug) TARGET	Coenzyme Q10 (drug)	University of Shizuoka	marketed	Mitochondrial cofactor / Antioxidant	Mitochondrial electron transport chain (Complexes I-III, Complex IV)
Q10 Coenzyme	Q10 Coenzyme	Central Hospital, Nancy, France	marketed	Mitochondrial cofactor / Antioxidant	Mitochondrial electron transport chain (Complexes I, II, III)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Mitochondrial cofactor / Antioxidant class)

Central Hospital, Nancy, France · 1 drug in this class
University of Shizuoka · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Coenzyme Q10 (drug) — Competitive Intelligence Brief. https://druglandscape.com/ci/coenzyme-q10-drug. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab